424 related articles for article (PubMed ID: 12798794)
1. Correlated NOS-Imu and myf5 expression by satellite cells in mdx mouse muscle regeneration during NOS manipulation and deflazacort treatment.
Anderson JE; Vargas C
Neuromuscul Disord; 2003 Jun; 13(5):388-96. PubMed ID: 12798794
[TBL] [Abstract][Full Text] [Related]
2. CAPON expression in skeletal muscle is regulated by position, repair, NOS activity, and dystrophy.
Ségalat L; Grisoni K; Archer J; Vargas C; Bertrand A; Anderson JE
Exp Cell Res; 2005 Jan; 302(2):170-9. PubMed ID: 15561099
[TBL] [Abstract][Full Text] [Related]
3. Persistent and improved functional gain in mdx dystrophic mice after treatment with L-arginine and deflazacort.
Archer JD; Vargas CC; Anderson JE
FASEB J; 2006 Apr; 20(6):738-40. PubMed ID: 16464957
[TBL] [Abstract][Full Text] [Related]
4. Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy.
Anderson JE; Weber M; Vargas C
Cell Transplant; 2000; 9(4):551-64. PubMed ID: 11038071
[TBL] [Abstract][Full Text] [Related]
5. A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells.
Anderson JE
Mol Biol Cell; 2000 May; 11(5):1859-74. PubMed ID: 10793157
[TBL] [Abstract][Full Text] [Related]
6. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice.
Wehling M; Spencer MJ; Tidball JG
J Cell Biol; 2001 Oct; 155(1):123-31. PubMed ID: 11581289
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-dependence of satellite stem cell activation and quiescence on normal skeletal muscle fibers.
Wozniak AC; Anderson JE
Dev Dyn; 2007 Jan; 236(1):240-50. PubMed ID: 17117435
[TBL] [Abstract][Full Text] [Related]
8. Deflazacort but not prednisone improves both muscle repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse.
Anderson JE; McIntosh LM; Poettcker R
Muscle Nerve; 1996 Dec; 19(12):1576-85. PubMed ID: 8941272
[TBL] [Abstract][Full Text] [Related]
9. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
10. Muscular nitric oxide synthase (muNOS) and utrophin.
Chaubourt E; Voisin V; Fossier P; Baux G; Israël M; De La Porte S
J Physiol Paris; 2002; 96(1-2):43-52. PubMed ID: 11755782
[TBL] [Abstract][Full Text] [Related]
11. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
Guo Y; Petrof BJ; Hussain SN
Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
[TBL] [Abstract][Full Text] [Related]
12. Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-deficient muscles.
McIntosh LM; Garrett KL; Megeney L; Rudnicki MA; Anderson JE
Anat Rec; 1998 Oct; 252(2):311-24. PubMed ID: 9776086
[TBL] [Abstract][Full Text] [Related]
13. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
14. In situ hybridization analysis for expression of myogenic regulatory factors in regenerating muscle of mdx mouse.
Bhagavati S; Ghatpande A; Shafiq SA; Leung B
J Neuropathol Exp Neurol; 1996 May; 55(5):509-14. PubMed ID: 8627340
[TBL] [Abstract][Full Text] [Related]
15. Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice.
Pietraszek-Gremplewicz K; Kozakowska M; Bronisz-Budzynska I; Ciesla M; Mucha O; Podkalicka P; Madej M; Glowniak U; Szade K; Stepniewski J; Jez M; Andrysiak K; Bukowska-Strakova K; Kaminska A; Kostera-Pruszczyk A; Jozkowicz A; Loboda A; Dulak J
Antioxid Redox Signal; 2018 Jul; 29(2):128-148. PubMed ID: 29669436
[TBL] [Abstract][Full Text] [Related]
16. Unacylated Ghrelin Enhances Satellite Cell Function and Relieves the Dystrophic Phenotype in Duchenne Muscular Dystrophy mdx Model.
Reano S; Angelino E; Ferrara M; Malacarne V; Sustova H; Sabry O; Agosti E; Clerici S; Ruozi G; Zentilin L; Prodam F; Geuna S; Giacca M; Graziani A; Filigheddu N
Stem Cells; 2017 Jul; 35(7):1733-1746. PubMed ID: 28436144
[TBL] [Abstract][Full Text] [Related]
17. iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin.
Louboutin JP; Rouger K; Tinsley JM; Halldorson J; Wilson JM
Mol Med; 2001 May; 7(5):355-64. PubMed ID: 11474581
[TBL] [Abstract][Full Text] [Related]
18. Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking alpha- and beta1-syntrophins.
Shiao T; Fond A; Deng B; Wehling-Henricks M; Adams ME; Froehner SC; Tidball JG
Hum Mol Genet; 2004 Sep; 13(17):1873-84. PubMed ID: 15238508
[TBL] [Abstract][Full Text] [Related]
19. Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle.
Wells KE; Torelli S; Lu Q; Brown SC; Partridge T; Muntoni F; Wells DJ
Neuromuscul Disord; 2003 Jan; 13(1):21-31. PubMed ID: 12467729
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-3 and nitric oxide synthase I in healthy and diseased skeletal muscle.
Gossrau R
Acta Histochem; 1998 Feb; 100(1):99-112. PubMed ID: 9542584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
